<bill session="116" type="s" number="2817" updated="2020-08-12T04:16:22Z">
  <state datetime="2019-11-07">REFERRED</state>
  <status>
    <introduced datetime="2019-11-07"/>
  </status>
  <introduced datetime="2019-11-07"/>
  <titles>
    <title type="short" as="introduced">End Price Gouging for Insulin Act</title>
    <title type="short" as="introduced">End Price Gouging for Insulin Act</title>
    <title type="display">End Price Gouging for Insulin Act</title>
    <title type="official" as="introduced">A bill to require the Secretary of Health and Human Services to establish an annual reference price for insulin products for purposes of Federal health programs, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="M001176"/>
  <cosponsors>
    <cosponsor bioguide_id="D000563" joined="2019-11-07"/>
  </cosponsors>
  <actions>
    <action datetime="2019-11-07">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2019-11-07" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
      <reference ref="CR S6479-6480" label="Sponsor introductory remarks on measure"/>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="116" relation="identical" number="5364"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Asia"/>
    <term name="Australia"/>
    <term name="Canada"/>
    <term name="Department of Health and Human Services"/>
    <term name="Europe"/>
    <term name="Executive agency funding and structure"/>
    <term name="France"/>
    <term name="Germany"/>
    <term name="Health care costs and insurance"/>
    <term name="Health programs administration and funding"/>
    <term name="Indian social and development programs"/>
    <term name="Inflation and prices"/>
    <term name="Italy"/>
    <term name="Japan"/>
    <term name="Medicaid"/>
    <term name="Medical research"/>
    <term name="Medicare"/>
    <term name="Netherlands"/>
    <term name="North America"/>
    <term name="Prescription drugs"/>
    <term name="Research administration and funding"/>
    <term name="Research and development"/>
    <term name="Retail and wholesale trades"/>
    <term name="Spain"/>
    <term name="Sweden"/>
    <term name="Switzerland"/>
    <term name="United Kingdom"/>
    <term name="Veterans' medical care"/>
  </subjects>
  <amendments/>
  <summary date="2019-11-07T05:00:00Z" status="Introduced in Senate">End Price Gouging for Insulin Act

This bill requires the Department of Health and Human Services to set a maximum price for insulin products for individuals and enrollees of federal health programs.</summary>
  <committee-reports/>
</bill>
